Condition: Gastric/Gastroesophageal Junction Adenocarcinoma · Sponsor: The First Affiliated Hospital of Xiamen University
To evaluate the initial efficacy and safety of paclitaxel for injection (albumin-bound) in combination with apatinib mesylate and adebrelimab in the treatment of locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma following the progression of previous immunotherapy.
This description comes directly from the study's public registry record.
Mingquan Cai · 13696908231 · mingquan035@163.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Xiamen University | Fuzhou, Fujian, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06415669